Subtyping of Cushing’s Syndrome: A Step Ahead
Experimental and Clinical Endocrinology & Diabetes · 01.12.2024 · 132 (12) · 659-669
DOI: 10.1055/a-2299-5065 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.12.2024. Verfasst von Irene Tizianel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine DIMED, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Cushing Syndrome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 95 Literaturangaben.
Abstract (Originalsprache)
Cushing’s Syndrome (CS) is a rare disease due to chronic endogenous cortisol secretion. In recent years, new developments have broadened the spectrum of differential diagnosis, traditionally categorized as adrenocorticotropic hormone (ACTH)-dependent and ACTH-independent forms. Moreover, increased awareness of the detrimental effects of cortisol on cardiometabolic health and the risk of cardiovascular events lead to increased diagnosis of mild forms, especially in the context of adrenal incidentalomas. This review provides an up-to-date narrative of the most recent literature regarding the challenges of CS diagnosis. After the description of the diagnostic tools available, the functional non-neoplastic hypercortisolism (formerly known as pseudo-Cushing state) is characterized, followed by the subtyping of the different conditions of hypercortisolism, including the differential diagnosis of ACTH-dependent forms and the management of adrenal hypercortisolism, with peculiar attention to the new genetic classification of adrenal CS, mild autonomous cortisol secretion, and bilateral adrenal adenomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine DIMED, University of Padova, Padova, Italy.
- Endocrine Disease Unit, University-Hospital of Padova, Padova, Italy.
ORCID-Profile: Irene Tizianel, Mattia Barbot, Filippo Ceccato
Zitieren
APA
Tizianel, I., Barbot, M., & Ceccato, F. (2024). Subtyping of Cushing’s Syndrome: A Step Ahead. Experimental and Clinical Endocrinology & Diabetes, 132(12), 659-669. https://doi.org/10.1055/a-2299-5065
Vancouver
Tizianel I, Barbot M, Ceccato F. Subtyping of Cushing’s Syndrome: A Step Ahead. Experimental and Clinical Endocrinology & Diabetes. 2024;132(12):659-669. doi:10.1055/a-2299-5065
BibTeX
@article{Tizianel2024,
author = {Tizianel, Irene and Barbot, Mattia and Ceccato, Filippo},
title = {Subtyping of Cushing’s Syndrome: A Step Ahead},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2024},
volume = {132},
number = {12},
pages = {659--669},
doi = {10.1055/a-2299-5065}
}
EUVIMED